Basophil-expressing genes related with the efficacy of sublingual immunotherapy.
Basophils have been implicated not only in allergy pathogenesis, but also in the efficacy of allergen immunotherapy (AIT). We recently conducted a clinical study of sublingual immunotherapy (SLIT) in patients with Japanese cedar pollinosis using a purified cedar allergen. Patients were stratified into the high-responder (HR) and non-responder (NR) groups, and comprehensive microarray analysis was performed on peripheral basophils in the patients from both groups. A total of 153 genes were found to be differentially expressed in the HR and NR patients. The majority of the differentially expressed genes were intracellular molecules and showed higher expression levels in HR patients than NR patients. The mRNA expression levels of the gene encoding D4, zinc, and double plant homeodomain (PHD) fingers family 2 (DPF2) were found to be significantly correlated with copy number variation (CNV). Genetic variation in the DPF2 gene and its expression in basophils is a candidate determinant for SLIT efficacy.